إعلان
إعلان
ENTA
Enanta Pharmaceuticals, Inc
13.13
USDبرعاية
-0.31
-2.31%
٠٩ يناير, ١٥:٥٩ UTC -5
مغلق
بعد الإغلاق
13.54
+0.40
+3.08%
تقارير أرباح ENTA
النسبة الإيجابية المفاجئة
ENTA تفوق 25 من 39 آخر التقديرات.
64%
التقرير التالي
بيانات التقرير القادم
٠٩ فبراير ٢٠٢٦
Estimate for Q1 26 (Revenue/ EPS)
$16.46M
/-$0.82
التغير الضمني من Q4 25 (Revenue/ EPS)
+8.84%
/-5.75%
التغير الضمني من Q1 25 (Revenue/ EPS)
-2.93%
/-21.90%
Enanta Pharmaceuticals, Inc earnings per share and revenue
On ١٧ نوفمبر ٢٠٢٥, ENTA reported earnings of -0.87 USD per share (EPS) for Q4 25, beating the estimate of -1.04 USD, resulting in a 16.46% surprise. Revenue reached 15.13 مليون, compared to an expected 16.28 مليون, with a -7.07% difference. The market reacted with a -3.59% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 6 المحللين forecast an EPS of -0.82 USD, with revenue projected to reach 16.46 مليون USD, implying an نقصان of -5.75% EPS, and زيادة of 8.84% in Revenue from the last quarter.
الأسئلة الشائعة
What were Enanta Pharmaceuticals, Inc's earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, Enanta Pharmaceuticals, Inc reported EPS of -$0.87, beating estimates by 16.46%, and revenue of $15.13M, -7.07% below expectations.
How did the market react to Enanta Pharmaceuticals, Inc's Q4 2025 earnings?
The stock price moved down -3.59%, changed from $12.82 before the earnings release to $12.36 the day after.
When is Enanta Pharmaceuticals, Inc expected to report next?
The next earning report is scheduled for ٠٩ فبراير ٢٠٢٦.
What are the forecasts for Enanta Pharmaceuticals, Inc's next earnings report?
Based on 6
المحللين, Enanta Pharmaceuticals, Inc is expected to report EPS of -$0.82 and revenue of $16.46M for Q1 2026.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان